Liverly - Mixed Reality Liver Disease Therapeutics

Liverly is one of the first mixed reality therapeutic tools in the world designed for Nonalcoholic Fatty Liver Disease (NAFLD), a chronic condition affecting 32% of the global population with no pharmaceutical treatments available. Liverly offers a unique, non-invasive experience, harnessing advanced research in circadian rhythm and autophagy to support liver health.



With Liverly, users embark on a serene spatial therapy journey, engaging with biomarker insights that empower proactive liver wellness. Transforming invisible biological processes into an intuitive, immersive experience, allowing users to visualize ATP levels, lysosomal activity, and autophagy markers with real-time feedback. Integrated autophagy timers, reactive oxygen species (ROS) graphs, and circadian alignment tools guide users through cellular therapy cycles. While designed for NAFLD, Liverly’s impact extends to broader liver health and overall well-being.



As one of the world’s first spatial therapeutic tool designed for chronic liver disease, Liverly introduces a new era of non-invasive, technology-driven healthcare, offering an unprecedented approach to liver health.